ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?

Mair Pedro de Souza; Fernanda Leite Souza Franceschi; Fernando Barroso Duarte; Diego Coutinho; Beatrice Araujo Duarte; Romelia Pinheiro Gonçalves Lemes; Vergilio Colturato

doi:10.46765/2675-374X.2020v2n1p16-19

ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?

Autores

Mair Pedro de Souza
Fernanda Leite Souza Franceschi
Fernando Barroso Duarte
Diego Coutinho
Beatrice Araujo Duarte
Romelia Pinheiro Gonçalves Lemes
Vergilio Colturato

DOI:

https://doi.org/10.46765/2675-374X.2020v2n1p16-19

Resumo

Mielodysplastic syndrome and hematopoietic stem cell transplantation based on genetic status.

Downloads

pdf (English)

Publicado

14/10/2020

Como Citar

de Souza, M. P., Franceschi, F. L. S., Duarte, F. B., Coutinho, D., Duarte, B. A., Lemes, R. P. G., & Colturato, V. (2020). ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?. JBMTCT, 1(3), 16–19. https://doi.org/10.46765/2675-374X.2020v2n1p16-19